Pharmaceutical manufacturing

July 13, 2018 - 1:11 pm
OKLAHOMA CITY (AP) — The federal Centers for Medicare and Medicaid Services has approved Oklahoma's Medicaid program for a first-in-the-nation drug pricing experiment that supporters say could save taxpayer dollars and provide patients with the most effective medications for their ailments. Under...
Read More
FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The Food and Drug Administration is considering easing the process for drugmakers to get approval to sell some prescription medicines over the counter, a move to offer consumers convenience and lower prices. FDA Commissioner Dr. Scott Gottlieb said Tuesday, July 17, 2018 that the agency has developed tentative guidelines for drugmakers to do so, while maintaining safety standards. (AP Photo/Andrew Harnik, File)
July 12, 2018 - 5:53 pm
The U.S. Food and Drug Administration said Thursday it wants to more aggressively fight medication shortages that have led to rationing of some drugs and disrupted patient care. The agency announced plans for a task force to find ways to improve the supply of crucial drugs. It's a new approach for...
Read More
July 10, 2018 - 8:17 pm
WASHINGTON (AP) — President Donald Trump says pharmaceutical company Pfizer is "rolling back price hikes, so American patients don't pay more." Trump is tweeting that he and Health Secretary Alex Azar discussed the issue Tuesday with Pfizer CEO Ian Read. Pfizer has issued a statement saying Read...
Read More
June 07, 2018 - 10:29 am
BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co. Bayer said Thursday that it is now the sole owner of the company and Monsanto shares will no longer trade on the New York Stock Exchange. Bayer has put the cost of...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 6:10 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More
June 04, 2018 - 2:42 am
BERLIN (AP) — German pharmaceutical company Bayer AG says it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on Thursday. The deal...
Read More
FILE - This Monday, May 23, 2016, file photo, shows the Bayer AG corporate logo displayed on a building of the German drug and chemicals company in Berlin. The German pharmaceutical giant has agreed, Tuesday, May 29, 2018, to the U.S. government's demand that it sell about $9 billion in agriculture businesses as condition for acquiring Monsanto Co., a U.S. seed and weed-killer maker. Antitrust regulators at the Justice Department say it's the biggest divestiture ever required for a merger. (AP Photo/Markus Schreiber, File)
May 29, 2018 - 6:30 pm
WASHINGTON (AP) — German pharmaceutical giant Bayer AG has agreed to the U.S. government's demand that it sell about $9 billion in agriculture businesses as the condition for acquiring Monsanto Co., a U.S. seed and weed-killer maker. Antitrust regulators at the Justice Department say it's the...
Read More

Pages